Výsledky vyhledávání

Akademický článek

On-treatment platelet reactivity in the era of new ADP receptor blockers: data from a real-world clinical practice

Autor: Skornova I, Samos M, Simonova R, Zolkova J, Stanciakova L, Vadelová L, Bolek T, Urban L, Kovar F, Stasko J, Galajda P, Kubisz P, Mokan M.

Publikováno v: Acta Medica Martiniana, Vol 18, Iss 2, Pp 34-39 (2018)

Objectives: Several studies have questioned the need for platelet function testing in patients treated with new ADP receptor blockers (ADPRB). The aim of this study was to evaluate the prevalence of high on-treatment platelet reactivity (HTPR) among

Externí odkaz: https://doaj.org/article/816ecca60eac4ff6bc30f3d0c1f571b5

Zobrazit plný text záznamu

Akademický článek

The Prevalence of Coronary Heart Disease, Stroke and Selected Co-Morbidities in Patients with Newly Diagnosed Type 2 Diabetes Population - Based on Cohort Study of Outpatients

Autor: Bukova Linda, Galajda P., Mokan M.

Publikováno v: Acta Medica Martiniana, Vol 13, Iss 1, Pp 33-43 (2013)

The prospective study analyses prevalence of coronary heart disease, stroke, elevated serum levels of ALT and GGT and prevalence of cancer diseases in patients with newly diagnosed type 2 diabetes mellitus, and usage of this epidemiological data in e

Externí odkaz: https://doaj.org/article/b743917c02e94334ab6f769c44ec19e8

Zobrazit plný text záznamu

Akademický článek

Role of VASP Phosphorylation Assay in Monitoring the Antiplatelet Therapy

Autor: Fedor Marian, Simonova R., Fedorova J., Skornova I., Duraj L., Samos M., Stasko J., Kovar F., Mokan M., Kubisz P.

Publikováno v: Acta Medica Martiniana, Vol 13, Iss 1, Pp 21-26 (2013)

Dual antiplatelet treatment with clopidogrel and aspirin represents standard regimen in prevention of thromboembolic events in patients with ischemic heart disease undergoing percutaneous coronary intervention (PCI). One of the greatest pitfalls of c

Externí odkaz: https://doaj.org/article/bfb31b913eae48acbb2ae945295fc4a5

Zobrazit plný text záznamu